News & Updates

Beta-blockers reduce mortality risk in older patients with HFrEF
Beta-blockers reduce mortality risk in older patients with HFrEF
16 May 2022

Use of beta-blockers results in a lower risk of all-cause mortality, but not of heart failure (HF) readmission, in older patients with HR with reduced ejection fraction (HFrEF), reports a recent study. Results are similar between patients admitted and not admitted from nursing homes.

Beta-blockers reduce mortality risk in older patients with HFrEF
16 May 2022
Allergic rhinitis tied to thromboembolic disease in pregnancy
Allergic rhinitis tied to thromboembolic disease in pregnancy
15 May 2022

Pregnant women with allergic rhinitis before and after childbirth see higher rates of thromboembolic (TE) disease and venous complications, a recent study has found.

Allergic rhinitis tied to thromboembolic disease in pregnancy
15 May 2022